Ozempic face in your 40s: comedy or clinical concern?

What did @kathbum actually say?

Katherine Ryan's video is a comedy bit, but it makes a real medical point. Her teenage daughter looked at her aging skin and diagnosed her with "Ozempic face," the term circulating on TikTok for facial volume loss associated with GLP-1 medications. Ryan's punchline: "This is what over 40 looks like." She's pushing back on a piece of health misinformation that's genuinely spreading among younger users, the idea that any loose or sagging facial skin in a middle-aged woman must be drug-related. The daughter also references people "going to hospital" and "getting very sick" from Ozempic, which is a separate claim worth examining. The core observation here, that normal aging is being rebranded as a drug side effect, is both funny and medically worth taking seriously.

Does the science back this up?

Mostly, yes. Age-related facial volume loss is well-documented and starts earlier than most people expect. Ryan is right that over-40 skin changes are real and common. That said, Ozempic face is not entirely made up either, which complicates the picture.

Rapid weight loss of any kind, whether from GLP-1 medications, bariatric surgery, or caloric restriction, can accelerate facial volume loss. A 2023 paper by Hwang et al. in Plastic and Reconstructive Surgery noted that significant weight loss reduces buccal fat and subcutaneous facial fat, which worsens the appearance of skin laxity. The issue is not the drug itself but the speed and magnitude of weight loss. Meanwhile, natural aging causes loss of collagen, elastin, and bone density in the face regardless of weight. These processes are independent and cumulative. Blaming Ozempic for what is simply middle-age skin change in someone who may not even be on the drug is a category error.

What did they get wrong (or right)?

Ryan gets the main point right. The term "Ozempic face" has been applied so loosely on social media that it now functions as a catch-all for any facial aging in anyone suspected of being on GLP-1 therapy. That is genuinely inaccurate. The daughter's logic, "your skin is hanging and wrinkly, therefore Ozempic," is not how medicine works.

However, Ryan's framing that the whole concept is a radicalized myth slightly oversimplifies. "Ozempic face" does describe a real phenomenon in people who lose weight rapidly on semaglutide. A 2022 commentary by Hartman et al. in the Journal of the American Academy of Dermatology acknowledged that GLP-1-associated weight loss can worsen facial hollowing in susceptible individuals. The issue is misapplication of the term, not its complete nonexistence. The daughter's claim that people are "going to hospital" from Ozempic is a real but context-free statement. Serious adverse events including pancreatitis and gastroparesis have been reported, but these are not the same as getting sick from facial skin changes.

What should you actually know?

Three things are getting conflated here and it matters clinically. First, normal aging causes facial volume loss in everyone, with or without GLP-1 medications. Second, rapid weight loss from any source, including semaglutide or tirzepatide, can accelerate visible facial aging in people who lose substantial weight quickly. Third, the term "Ozempic face" is being used on TikTok in a way that has almost no diagnostic value because it is applied to anyone over 35 with visible aging, regardless of actual medication use.

If you are on a GLP-1 medication and concerned about facial changes, that is worth a conversation with a prescribing clinician. The rate of weight loss, not just the total amount, appears to be a factor in how pronounced facial volume changes are. There is no evidence that semaglutide causes skin changes independently of weight loss effects. And if you are a teenager diagnosing your mum on TikTok, that is not a clinical assessment.